Nemaura Medical (NMRD) Expected to Post Quarterly Earnings on Monday

by · The Markets Daily

Nemaura Medical (OTCMKTS:NMRD – Get Free Report) is expected to announce its resultson Monday, August 10th. Analysts expect the company to post earnings of ($0.08) per share and revenue of $0.20 million for the quarter.

Nemaura Medical Trading Up 9,900.0%

Shares of OTCMKTS NMRD traded up $0.00 during trading on Monday, reaching $0.00. The company had a trading volume of 800 shares, compared to its average volume of 3,367. Nemaura Medical has a 52 week low of $0.00 and a 52 week high of $0.05. The company has a market cap of $4,035.00, a PE ratio of -0.00 and a beta of 0.46.

Nemaura Medical Company Profile

(Get Free Report)

Nemaura Medical PLC is a medical technology company focused on developing non‐invasive monitoring solutions for diabetes management and other metabolic applications. The company’s core offering centers on sugarBEAT, a wearable continuous glucose monitoring (CGM) system designed to provide real-time glucose readings through a disposable skin patch. By eliminating the need for finger-stick testing, Nemaura aims to improve patient comfort and adherence, particularly for individuals managing type 1 and type 2 diabetes.

The sugarBEAT system utilizes a proprietary, mild electric current to extract interstitial fluid through micro-pores in the skin, enabling glucose measurement without needle penetration.

See Also